Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;92(6):295-304.
doi: 10.1097/MD.0000000000000007.

High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature

Affiliations
Review

High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature

Jose A Gómez-Puerta et al. Medicine (Baltimore). 2013 Nov.

Abstract

Multifocal or multiple osteonecrosis (ON), defined by the involvement of 3 or more anatomic sites, is unusual, being observed in only 3%-10% of patients diagnosed with ON. We report the clinical characteristics of a cohort of 29 patients with multifocal ON from a single center and evaluate the prevalence of associated prothrombotic abnormalities in 26 of these patients. We conducted a retrospective study of all patients diagnosed with multifocal ON evaluated in our institution during the last 20 years. We recorded clinical manifestations and underlying diagnoses. A wide thrombophilic profile was performed, including antithrombin, protein C, protein S, lupus anticoagulant, anticardiolipin antibodies, activated protein C resistance, factor V Leiden, mutation G-20210-A of the prothrombin gene, and factor VIII. Coagulation test results were compared with those in a healthy control group and a group of patients with history of lower-extremity deep venous thrombosis. The mean age of the patients was 49.2 ± 15 years (range, 28-81 yr). The mean number of ON localizations per patient was 5.2 ± 2.3 (range, 3-11). Hips were the most commonly affected joint (82%), followed by knees (58%), shoulders (37%), and ankles (13%). Most patients had an underlying disease process, and 12 of 25 (48%) patients had coagulation test abnormalities. The most common alterations were high factor VIII levels and antiphospholipid antibody (aPL) positivity in 24% and 20% of cases, respectively. These abnormalities were more prevalent in patients with multifocal ON compared with patients in the control groups. Sixty-one percent of patients had a history of corticosteroid treatment. Patients with coagulation abnormalities had a higher number of ON localizations per patient (6.5 ± 2.7 vs. 3.88 ± 0.8; p = 0.002) and a higher prevalence of atypical ON localizations (25% vs. 0%; p = 0.05). In conclusion, in the present cohort of patients with multifocal ON, 48% of the patients had at least 1 prothrombotic factor, especially high levels of factor VIII and aPL. These findings have major implications for the diagnosis and treatment of multifocal ON and clearly indicate the need to perform a thrombophilic profile in these patients.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Bilateral knee X-rays showing extensive bilateral bone infarcts in the distal femur and proximal tibia. (“D” indicates the right side.)
FIGURE 2
FIGURE 2
Bilateral ankle X-rays showing bilateral bone infarcts in the distal tibia and fibula. (“D” indicates the right side.)
FIGURE 3
FIGURE 3
Sagittal MRI demonstrating serpentine areas of bone infarcts in the distal tibia and talus and ON of cuneiform bone.

References

    1. Alijotas J, Argemi M, Barquinero J. Kienbock’s disease and antiphospholipid antibodies. Clin Exp Rheumatol. 1990; 8: 297– 298. - PubMed
    1. Anonymous. Symptomatic multifocal osteonecrosis. A multicenter study. Collaborative Osteonecrosis Group. Clin Orthop Relat Res. 1999; 369: 312– 326. - PubMed
    1. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GR. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore). 1989; 68: 366– 374. - PubMed
    1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002; 32: 94– 124. - PubMed
    1. Blanche P, Si-Larbi AG, Jouve P. Femoral head necrosis and hyperhomocysteinemia. J Rheumatol. 2001; 28: 1469. - PubMed